HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

lexgenleucel-T

lexgenleucel-T refers to the lentiviral vector

Also Known As:

VRX496

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleotides: 15763
  - Polynucleotides: 218
    - Oligonucleotides: 5145
      - lexgenleucel-T: 3

Experts

1.	June, Carl H: 2 articles (02/2013 - 06/2004)
2.	Levine, Bruce L: 2 articles (02/2013 - 06/2004)
3.	Slepushkin, Vladimir: 2 articles (02/2013 - 06/2004)
4.	Aberra, Faten: 1 article (02/2013)
5.	Binder-Scholl, Gwendolyn: 1 article (02/2013)
6.	Boyer, Jean: 1 article (02/2013)
7.	Brady, Troy: 1 article (02/2013)
8.	Brennan, Andrea L: 1 article (02/2013)
9.	Bushman, Frederic D: 1 article (02/2013)
10.	Collman, Ronald G: 1 article (02/2013)

Related Diseases

1.	Acquired Immunodeficiency Syndrome (AIDS) 06/01/2004 - "Transfer of autologous CD4(+) T lymphocytes genetically modified with VRX496 (VRX496T) into HIV-infected patients is intended to provide a reservoir of cells capable of controlling HIV, potentially delaying AIDS onset. " 11/01/2001 - "Data from in vitro studies suggest that HIV vectors such as VRX496 could potentially reduce viral loads in HIV-infected individuals and thus could delay the onset to AIDS while promoting CD4 T cell survival and providing the immune system with a better chance to control the infection. "
2.	Infections 11/01/2001 - "Data from in vitro studies suggest that HIV vectors such as VRX496 could potentially reduce viral loads in HIV-infected individuals and thus could delay the onset to AIDS while promoting CD4 T cell survival and providing the immune system with a better chance to control the infection. "
3.	Viremia 02/28/2013 - "We report the safety and tolerability of 87 infusions of lentiviral vector–modified autologous CD4 T cells (VRX496-T; trade name, Lexgenleucel-T) in 17 HIV patients with well-controlled viremia. "

Related Drugs and Biologics

1.	lexgenleucel-T